Article: Ym Biosciences Reports Positive Nimotuzumab Four-year Survival Data Presented At Astro 2009.(Clinical report)

Article: NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & ...
PR Newswire;  June 1, 2009 ;     700+ words ... ... randomized trial of nimotuzumab (aka BIOMAb/TheraCIM ... III/IVa head and neck cancer conducted by Reddy ... that the efficacy of nimotuzumab compares favorably ... 60% of head and neck cancer patients. A total ... evaluable. The addition of nimotuzumab to both the radiation ...

Article: YM BioSciences reports anti-EGFr drug nimotuzumab approved ...
PR Newswire;  July 20, 2006 ;     700+ words ... ... marketing approval to nimotuzumab, an anti-EGFr ... head & neck cancer. Biocon Biopharmaceuticals ... subcontinent. Nimotuzumab is also licensed ... head & neck cancer will be now generated in India as nimotuzumab is commercialized ...

Article: YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR ...
PR Newswire;  November 2, 2009 ;     700+ words ... ... advanced head and neck cancer but there was no evidence that nimotuzumab's activity ... of head and neck cancer with radiation ... differentiate nimotuzumab which, as first ... activity of nimotuzumab in head and neck cancer, which includes ...

Article: YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE ...
PR Newswire;  March 13, 2009 ;     700+ words ... ... accumulating clinical data on nimotuzumab, demonstrate that, where ... radiation-containing regimens, nimotuzumab would be expected to have ... radiation dermatitis in head and neck cancer, reportedly not previously ... nature of differentiation of nimotuzumab from the other anti-EGFR ...

Article: YM BIOSCIENCES INC. - YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB ...
PR Newswire UK Disclose;  March 13, 2009 ;     700+ words ... ... accumulating clinical data on nimotuzumab, demonstrate that, where ... radiation-containing regimens, nimotuzumab would be expected to have ... radiation dermatitis in head and neck cancer, reportedly not previously ... nature of differentiation of nimotuzumab from the other anti-EGFR ...

Article: YM BioSciences reports successful regulatory reviews of ...
PR Newswire;  May 24, 2007 ;     700+ words ... ... About Nimotuzumab Nimotuzumab is a humanized ... types of head and neck cancer. Global development of nimotuzumab through a number ... stage products: nimotuzumab, a humanized monoclonal ... types of head and neck cancer, and AeroLEF ...

Article: YM BioSciences announces preclinical data confirming ...
PR Newswire;  July 9, 2007 ;     700+ words ... ... Kalbiotech in Southeast Asia. Nimotuzumab is approved for sale in India ... intention to initiate trials with nimotuzumab in colorectal cancer and ... two late-stage products: nimotuzumab, a humanized monoclonal ... various types of head and neck cancer; and AeroLEF(TM), a ...